| pubmed-article:17822344 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17822344 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:17822344 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:17822344 | lifeskim:mentions | umls-concept:C0085631 | lld:lifeskim |
| pubmed-article:17822344 | lifeskim:mentions | umls-concept:C0380393 | lld:lifeskim |
| pubmed-article:17822344 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
| pubmed-article:17822344 | lifeskim:mentions | umls-concept:C0541653 | lld:lifeskim |
| pubmed-article:17822344 | lifeskim:mentions | umls-concept:C0442117 | lld:lifeskim |
| pubmed-article:17822344 | lifeskim:mentions | umls-concept:C1514923 | lld:lifeskim |
| pubmed-article:17822344 | lifeskim:mentions | umls-concept:C0871869 | lld:lifeskim |
| pubmed-article:17822344 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17822344 | pubmed:dateCreated | 2007-9-7 | lld:pubmed |
| pubmed-article:17822344 | pubmed:abstractText | Our primary objective was to evaluate the effectiveness and tolerability of intramuscular ziprasidone for impulsivity and agitation in psychiatrically hospitalized children and adolescents. Our secondary objective was to examine demographic and clinical factors associated with treatment response. | lld:pubmed |
| pubmed-article:17822344 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17822344 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17822344 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17822344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17822344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17822344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17822344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17822344 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17822344 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:17822344 | pubmed:issn | 1044-5463 | lld:pubmed |
| pubmed-article:17822344 | pubmed:author | pubmed-author:KeckPaul... | lld:pubmed |
| pubmed-article:17822344 | pubmed:author | pubmed-author:StrakowskiSte... | lld:pubmed |
| pubmed-article:17822344 | pubmed:author | pubmed-author:DelBelloMelis... | lld:pubmed |
| pubmed-article:17822344 | pubmed:author | pubmed-author:BarzmanDrew... | lld:pubmed |
| pubmed-article:17822344 | pubmed:author | pubmed-author:ForresterJaco... | lld:pubmed |
| pubmed-article:17822344 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17822344 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:17822344 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17822344 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17822344 | pubmed:pagination | 503-9 | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:meshHeading | pubmed-meshheading:17822344... | lld:pubmed |
| pubmed-article:17822344 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17822344 | pubmed:articleTitle | A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed. | lld:pubmed |
| pubmed-article:17822344 | pubmed:affiliation | Children's Hospital Medical Center, Division of Child and Adolescent Psychiatry, Cincinnati, Ohio 45229-3039, USA. drew.barzman@fuse.net | lld:pubmed |
| pubmed-article:17822344 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17822344 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17822344 | lld:pubmed |
